In a univariate logistic regression analysis, a high-risk IL-6 promoter genotype profile was significantly and strongly associated with increased risk of relapsed breast cancer (OR 7.19, 95% CI 1.47–35.30, p = 0.015). This evidence concerns the gene IL6 and breast cancer.